159 related articles for article (PubMed ID: 7539263)
1. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.
Ho JJ; Cheng S; Kim YS
Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
3. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
Ho JJ; Siddiki B; Kim YS
Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
[TBL] [Abstract][Full Text] [Related]
4. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
Burchell J; Taylor-Papadimitriou J
Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
[TBL] [Abstract][Full Text] [Related]
7. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
[TBL] [Abstract][Full Text] [Related]
8. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.
Byrd JC; Ho JJ; Lamport DT; Ho SB; Siddiki B; Huang J; Yan PS; Kim YS
Cancer Res; 1991 Feb; 51(3):1026-33. PubMed ID: 1988113
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
10. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis and pancreatic cancer cells synthesize and secrete MUC1 type mucin gene product.
Dahiya R; Kwak KS; Ho SB; Yoon WH; Kim YS
Biochem Mol Biol Int; 1995 Feb; 35(2):351-62. PubMed ID: 7545050
[TBL] [Abstract][Full Text] [Related]
12. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
[TBL] [Abstract][Full Text] [Related]
13. Second generation anti-MUC1 peptide monoclonal antibodies.
Xing PX; Prenzoska J; Quelch K; McKenzie IF
Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
[TBL] [Abstract][Full Text] [Related]
14. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
[TBL] [Abstract][Full Text] [Related]
15. Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness.
Sawada T; Ho JJ; Sagabe T; Yoon WH; Chung YS; Sowa M; Kim YS
Biochem Biophys Res Commun; 1993 Sep; 195(2):1096-103. PubMed ID: 8373388
[TBL] [Abstract][Full Text] [Related]
16. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
18. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
[TBL] [Abstract][Full Text] [Related]
20. Cell-to-cell heterogeneity in the expression of carbohydrate-based epitopes of a mucin-type glycoprotein on the surface of human mammary carcinoma cells.
Moss L; Greenwalt D; Cullen B; Dinh N; Ranken R; Parry G
J Cell Physiol; 1988 Nov; 137(2):310-20. PubMed ID: 2461377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
